For: | Ierardi E, Rosania R, Zotti M, Giorgio F, Prencipe S, Valle ND, Francesco VD, Panella C. From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways. World J Gastrointest Oncol 2010; 2(6): 259-264 [PMID: 21160638 DOI: 10.4251/wjgo.v2.i6.259] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v2/i6/259.htm |
Number | Citing Articles |
1 |
Ariel Ka-Man Chow, Simon Wing-Lung Yau, Lui Ng. Novel molecular targets in hepatocellular carcinoma. World Journal of Clinical Oncology 2020; 11(8): 589-605 doi: 10.5306/wjco.v11.i8.589
|
2 |
Hoang Van Tong, Pham Van Dung, Nguyen Thi Mong Diep, Nguyen Linh Toan. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.98483
|
3 |
Guo-Shiou Liao, Ching-Hui Lo, Teng-Wei Chen, Jyh-Cherng Yu, Hung-Cheng Lai, Chung-Bao Hsieh, Tsan-Pai Liu. Fas/FasL polymorphisms are associated with hepatitis C related cirrhosis and serum Alpha-Fetoprotein with hepatocellular carcinoma patients. Journal of Cancer Research and Practice 2016; 3(1): 9 doi: 10.1016/j.jcrpr.2015.10.006
|
4 |
Yangyang Hu, Shengpeng Wang, Xu Wu, Jinming Zhang, Ruie Chen, Meiwan Chen, Yitao Wang. Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma. Journal of Ethnopharmacology 2013; 149(3): 601 doi: 10.1016/j.jep.2013.07.030
|
5 |
Vladimir Pecenka, Petr Pajer, Vít Karafiat, Petra Kasparova, Jana Dudlova, Michal Dvorak, Karen L. Beemon.
HRAS
,
EGFR
,
MET
, and
RON
Genes Are Recurrently Activated by Provirus Insertion in Liver Tumors Induced by the Retrovirus Myeloblastosis-Associated Virus 2
. Journal of Virology 2017; 91(20) doi: 10.1128/JVI.00467-17
|
6 |
Kulsoom Bibi, Tehseen Fatima, Saba Sohrab, Ghulam Haider, Shamshad Zarina, Amber Ilyas. Polymorphic Variants of ASS1 Gene Related to Arginine Metabolism and
the Risk of HCC. Protein & Peptide Letters 2023; 30(7): 587 doi: 10.2174/0929866530666230529143121
|